Commit To Purchase Fate Therapeutics At $2.50, Earn 22.1% Annualized Using Options
August 08, 2024 at 11:38 AM EDT
Investors eyeing a purchase of Fate Therapeutics Inc (FATE) shares, but tentative about paying the going market price of $3.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $2.50 strike, which has a bid at the time of this writing of 15 cents..